Web3 to therapeutic applications in 2024. Blue Earth Diagnostics has two Phase 3 clinical studies evaluating the safety and diagnostic performance of 18F‐rhPSMA‐7.3 PET … WebOct 25, 2024 · Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and …
Evolving Role of Prostate-Specific Membrane Antigen-Positron …
WebJun 27, 2024 · BURLINGTON, Mass. & OXFORD, United Kingdom-- ( BUSINESS WIRE )-- Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that a definitive agreement has been signed for Bracco Imaging S.p.A. to acquire all outstanding shares of privately-held Blue Earth Diagnostics from leading healthcare company … WebJun 27, 2024 · Blue Earth Diagnostics's latest funding round was a Acquired for on June 27, 2024. Blue Earth Diagnostics's latest post-money valuation is from June 2024. Sign … summertech logo
A Global Leader in Diagnostic Imaging. - Blue Earth …
WebFeb 16, 2024 · Blue Earth Diagnostics has completed two Phase 3 clinical studies evaluating the safety and diagnostic performance of 18 F-rhPSMA-7.3 PET imaging in prostate cancer: ("SPOTLIGHT," NCT04186845), in ... WebJun 27, 2024 · Imaging company Bracco is to buy Blue Earth Diagnostics for $450 million, netting £337 million for its owner Syncona, the UK’s largest listed life sciences investment firm. WebBlue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics' success is driven by our management expertise and agility, supported by our demonstrated ... summer tech internships ottawa